BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 4 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 6 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 7 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 7 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 8 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 10 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 10 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 11 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 11 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 4 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 6 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 7 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 7 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 8 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 10 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 10 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 11 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 11 hours ago
ADVERTISEMENT
AlphaGraphs

Infographic: Tilray reports narrower Q3 loss on higher revenues

Cannabis company Tilray, Inc. (NASDAQ: TLRY) Tuesday announced financial results for the third quarter of 2024, reporting a narrower net loss and double-digit revenue growth. The company reported a net loss of $105 million or $0.12 per share for the three months ended February 2024, compared to a loss of $1.20 billion or $1.90 per […]

April 9, 2024 1 min read

Cannabis company Tilray, Inc. (NASDAQ: TLRY) Tuesday announced financial results for the third quarter of 2024, reporting a narrower net loss and double-digit revenue growth.

Tilray Q3 2024 earnings infographic

The company reported a net loss of $105 million or $0.12 per share for the three months ended February 2024, compared to a loss of $1.20 billion or $1.90 per share in the prior year period. Adjusted cannabis gross profit decreased by 5% year-over-year to $21.1 million in Q3.

The improvement in bottom line performance reflects a 29% growth in third-quarter revenues to $188.3 million. At $10.2 million, adjusted EBITDA was down 23%.

ADVERTISEMENT